How Zimmer Biomet Zoomed Past Wall Street's Third-Quarter Estimates

All you have to do to understand how the coronavirus pandemic has impacted Zimmer Biomet Holdings (NYSE: ZBH) is to look at its stock chart. The musculoskeletal healthcare company's shares plunged nearly 50% earlier this year and still haven't completely recovered.

Zimmer Biomet announced its third-quarter results before the market opened on Friday, and it looks like its business is bouncing back better than expected. Here are the highlights from the quarterly update.

Hip replacement implant. Image source: Getty Images.

Source Fool.com